DK237282A - Fremgangsmaade til bestemmelse af antithrambin-bm - Google Patents
Fremgangsmaade til bestemmelse af antithrambin-bm Download PDFInfo
- Publication number
- DK237282A DK237282A DK237282A DK237282A DK237282A DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A
- Authority
- DK
- Denmark
- Prior art keywords
- antithrombin
- heparin
- determining
- cofactor
- thrombin
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 3
- 108090000190 Thrombin Proteins 0.000 abstract 3
- 239000004019 antithrombin Substances 0.000 abstract 3
- 229960004072 thrombin Drugs 0.000 abstract 3
- 229960002897 heparin Drugs 0.000 abstract 2
- 229920000669 heparin Polymers 0.000 abstract 2
- 239000000758 substrate Substances 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000002628 heparin derivative Substances 0.000 abstract 1
- 239000012488 sample solution Substances 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 229920001221 xylan Polymers 0.000 abstract 1
- 150000004823 xylans Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8128—Antithrombin III
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803038163 DE3038163A1 (de) | 1980-10-09 | 1980-10-09 | Thrombininhibitor, seine herstellung und verwendung |
| DE3038163 | 1980-10-09 | ||
| DE3050268 | 1981-08-04 | ||
| DE3050268 | 1981-08-04 | ||
| DE8100170 | 1981-10-08 | ||
| PCT/DE1981/000170 WO1982001377A1 (en) | 1980-10-09 | 1981-10-08 | Method for determining a bm-antithrombin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK237282A true DK237282A (da) | 1982-05-26 |
| DK160511B DK160511B (da) | 1991-03-18 |
| DK160511C DK160511C (da) | 1991-09-30 |
Family
ID=25788386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK237282A DK160511C (da) | 1980-10-09 | 1982-05-26 | Fremgangsmaade og reagens til bestemmelse af antithrombin-bm |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4496653A (da) |
| EP (1) | EP0049877B1 (da) |
| JP (1) | JPH0258920B2 (da) |
| DE (1) | DE3163764D1 (da) |
| DK (1) | DK160511C (da) |
| WO (1) | WO1982001377A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3407280A1 (de) * | 1984-02-28 | 1985-09-19 | Gödecke AG, 1000 Berlin | Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit |
| DE3512909A1 (de) * | 1985-04-11 | 1986-10-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung von plasminogenaktivatoren (pa) |
| NL8902406A (nl) * | 1989-09-27 | 1991-04-16 | Hendrik Coenraad Hemker Prof D | Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit. |
| US5595735A (en) * | 1990-05-23 | 1997-01-21 | Johnson & Johnson Medical, Inc. | Hemostatic thrombin paste composition |
| CA2070813C (en) * | 1990-11-05 | 1996-10-29 | Hendrik Coenraad Hemker | A method to determine the concentration of anticoagulants |
| DE4203980A1 (de) * | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Verfahren zur bestimmung von hirudin und synthetischen thrombininhibitoren |
| AT397391B (de) * | 1992-05-15 | 1994-03-25 | Immuno Ag | Verwendung von prothrombinfragmenten |
| US5476771A (en) * | 1993-02-22 | 1995-12-19 | The United States Of America As Represented By The Secretary Of The Army | Test for quantitative thrombin time |
| WO1993025220A1 (en) * | 1992-06-05 | 1993-12-23 | Reid Thomas J Iii | Test for quantitative thrombin time |
| US5308755A (en) * | 1992-06-08 | 1994-05-03 | Research Corporation Technologies, Inc. | Method for measuring heparin |
| US5985582A (en) * | 1997-12-09 | 1999-11-16 | Sigma-Aldrich Co. | Thrombin-based assay for antithrombin III |
| WO2016049506A1 (en) | 2014-09-26 | 2016-03-31 | Abbott Point Of Care Inc. | Sensors for assaying coagulation in fluid samples |
| WO2016049533A1 (en) | 2014-09-26 | 2016-03-31 | Abbott Point Of Care Inc. | Cartridge device with fluidic junctions for coagulation assays in fluid samples |
| EP3198281B1 (en) | 2014-09-26 | 2023-01-25 | Abbott Point Of Care, Inc. | Ellagic acid formulations for use in coagulation assays |
| US10114031B2 (en) | 2014-09-26 | 2018-10-30 | Abbott Point Of Care Inc. | Single channel cartridge device for coagulation assays in fluid samples |
| WO2016049527A1 (en) | 2014-09-26 | 2016-03-31 | Abbott Point Of Care Inc. | Cartridge device with segmented fluidics for assaying coagulation in fluid samples |
| WO2016049515A1 (en) | 2014-09-26 | 2016-03-31 | Abbott Point Of Care Inc. | Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples |
| CN107107057B (zh) | 2014-09-26 | 2020-12-15 | 雅培医护站股份有限公司 | 用于流体样本中的凝结测定的盒设备识别 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH622286A5 (da) * | 1975-06-23 | 1981-03-31 | Pentapharm Ag | |
| SE419871B (sv) * | 1975-12-01 | 1981-08-31 | Pharmacia Ab | Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod |
| DE2601372C3 (de) * | 1976-01-15 | 1980-03-27 | Behringwerke Ag, 3550 Marburg | Verfahren zur Bestimmung von Antithrombin III |
| DE2812943C3 (de) * | 1978-03-23 | 1981-05-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma |
| US4216142A (en) * | 1978-12-18 | 1980-08-05 | Abbott Laboratories | Chromogenic substrates for the proteolytic enzymes |
| CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| EP0018002B1 (de) * | 1979-04-24 | 1983-02-09 | Marcel Jozefonvicz | Neues Bestimmungsverfahren für Proteasen und Antiproteasen |
| CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
-
1981
- 1981-10-08 WO PCT/DE1981/000170 patent/WO1982001377A1/de not_active Ceased
- 1981-10-08 US US06/394,998 patent/US4496653A/en not_active Expired - Fee Related
- 1981-10-08 DE DE8181108116T patent/DE3163764D1/de not_active Expired
- 1981-10-08 JP JP56503268A patent/JPH0258920B2/ja not_active Expired - Lifetime
- 1981-10-08 EP EP81108116A patent/EP0049877B1/de not_active Expired
-
1982
- 1982-05-26 DK DK237282A patent/DK160511C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0049877A1 (de) | 1982-04-21 |
| EP0049877B1 (de) | 1984-05-23 |
| DE3163764D1 (en) | 1984-06-28 |
| JPH0258920B2 (da) | 1990-12-11 |
| DK160511B (da) | 1991-03-18 |
| DK160511C (da) | 1991-09-30 |
| WO1982001377A1 (en) | 1982-04-29 |
| US4496653A (en) | 1985-01-29 |
| JPS57501510A (da) | 1982-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK237282A (da) | Fremgangsmaade til bestemmelse af antithrambin-bm | |
| Fletcher et al. | Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products | |
| EP0420332B1 (en) | Method for determining the endogenous thrombin potential of plasma and blood, and also a kit for use in said method | |
| Mannello et al. | Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases | |
| ATE35000T1 (de) | Reagenz zur bestimmung der thromboplastinzeit. | |
| EP0171960B1 (en) | An alpha-amylase assay method and reagent kit | |
| Zucker | Proteolytic inhibitors, contact and other variables in the release reaction of human platelets | |
| ES2154249T1 (es) | Estabilizador reactivo para diagnostico. | |
| SE7902555L (sv) | Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma | |
| Trundle et al. | Iodine oxidation of the sulfhydryl groups of creatine kinase | |
| ATE117311T1 (de) | Substrate für hydrolasen, verfahren zu ihrer herstellung und ihre verwendung. | |
| Lewis et al. | Automated discrete kinetic method for erythrocyte acetylcholinesterase and plasma cholinesterase. | |
| DD156295A6 (de) | Verfahren zur bestimmung der biologischen aktivitaet von heparin | |
| IE42546L (en) | Method of measuring serum coagulability | |
| PT87522A (pt) | Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern | |
| ES2053457T3 (es) | Ensayo de hibridacion en fase solucion para detectar secuencias de polinucleotidos. | |
| ATE52340T1 (de) | Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit. | |
| Kindness et al. | Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas | |
| ATE36557T1 (de) | Verfahren zur bestimmung der wirksamkeit von substraten oder enzymen. | |
| BR8003477A (pt) | Processo para produzir oxidase de alcool, processo para a determinacao da concentracao de um composto em uma amostra fluida e processo para a oxidacao de um alcool | |
| DE3663684D1 (de) | Determination of prokallikrein | |
| French et al. | A comparison of methods for measuring acetyl cholinesterase activity in blood samples inhibited by carbamates | |
| Andersen et al. | The antiheparin effect of α1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time | |
| Siegl | [29] Receptors for PGI2 and PGD2 on human platelets | |
| Johnson et al. | Effect of oral anticoagulant (Marcumar) on prothrombin and related components in blood coagulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |